The burgeoning Indian beauty and wellness sector, particularly the segment focused on advanced and personalized skincare, continues to attract significant investor interest. In a notable development underscoring this trend, Gurugram-based skin clinic startup KorinMi has successfully raised Rs 10 crore in a strategic growth investment from Lotus Herbals’ Innovation Fund. This capital infusion arrives at a pivotal moment, poised to accelerate KorinMi’s ambitious plans for geographic expansion and solidify its unique position at the intersection of Korean dermatological science and customized clinical treatments for the Indian market.
The investment by Lotus Herbals, a venerable name in the Indian beauty industry, signifies a strategic endorsement of KorinMi’s model and the growing consumer demand for specialized, results-driven skincare solutions. It highlights a clear market signal: Indian consumers are increasingly sophisticated, seeking treatments that combine global best practices with local relevance. KorinMi, with its distinctive approach, appears well-equipped to capture a substantial share of this evolving market.
About KorinMi: Blending K-Beauty with Clinical Precision for Indian Skin
Founded in 2024 by Reshbha Munjal and Jenovia Daun Jung, KorinMi emerged from a vision to bridge the gap between the acclaimed innovations of Korean skincare and the specific dermatological needs of Indian complexions. The startup operates on a dual model, establishing advanced physical clinics that offer a range of specialized treatments while simultaneously building a direct-to-consumer (D2C) line of skincare products. This integrated approach ensures a comprehensive skincare journey for its clientele, from in-clinic professional care to at-home maintenance.
KorinMi’s core philosophy revolves around delivering authentic Korean skin science through clinical, customized treatments. The brand meticulously tailors its protocols to suit diverse Indian skin types and concerns, a crucial differentiator in a market often flooded with generic solutions. Its services extend beyond facial treatments to include specialized hair care, addressing a broader spectrum of aesthetic and wellness needs. The company prides itself on sourcing equipment and products directly from South Korea, ensuring access to cutting-edge technology and formulations.
Since launching its inaugural clinic in Gurugram in October 2024, KorinMi has demonstrated impressive early traction, serving over 3,000 clients within its first few months of operation. The typical treatment cycle, often spanning 30 to 45 days, emphasizes a sustained approach to skin health, with the D2C product range designed to support clients throughout this journey. These products, manufactured in Korea, are specifically formulated to perform optimally under Indian weather conditions, a thoughtful consideration that resonates deeply with local consumers.
This latest funding round follows an earlier seed capital raise of Rs 3 crore in May last year from a consortium of angel investors, including Vikas Agarwal, the former CEO of Kaya Skin Clinic (UAE). That initial backing provided the runway for KorinMi to establish its foundational operations and validate its market hypothesis, paving the way for this more significant strategic investment.
The Strategic Investment: A Vote of Confidence from Lotus Herbals
The Rs 10 crore investment in KorinMi comes from the Lotus Herbals’ Innovation Fund, a dedicated vehicle with a corpus of $50 million specifically allocated to invest in early-stage beauty and wellness startups across India. This move by Lotus Herbals, a company with decades of experience in the Indian beauty landscape, is particularly insightful. It signals a clear strategic intent to diversify its portfolio, tap into emerging market trends, and potentially foster synergistic relationships with innovative younger brands.
While the exact valuation for this round was not publicly disclosed, an investment of this size from a strategic corporate fund at KorinMi’s early stage implies a strong belief in its growth potential and market-fit. For Lotus Herbals, the attraction to KorinMi likely stems from several factors. Firstly, KorinMi’s focus on clinical and specialized skincare aligns with the broader premiumization trend in the beauty market. Consumers are increasingly seeking scientifically backed, effective solutions rather than merely cosmetic fixes.
Secondly, the explicit emphasis on Korean skin science is a powerful draw. K-beauty has captivated global audiences, and its influence in India is undeniable. By investing in KorinMi, Lotus Herbals gains exposure to this trend and a brand that has successfully localized its appeal for Indian consumers. Furthermore, KorinMi’s hybrid model of physical clinics and D2C products offers a multi-channel approach that could be attractive from a distribution and brand-building perspective.
This investment is not an isolated incident for Lotus Herbals. The company previously acquired a 32% stake in skincare brand Fixderma in October 2021, demonstrating a consistent strategy of investing in and partnering with brands that operate in the derma-cosmetic and specialized skincare segments. Such strategic maneuvers allow established players like Lotus Herbals to stay agile, innovate from the outside, and capture newer market segments without having to build from scratch.
Focused Deployment: Powering Multi-City Expansion
The fresh capital infusion of Rs 10 crore is earmarked for a clear and ambitious growth trajectory: opening new clinics and expanding KorinMi’s footprint into major metropolitan areas across India. Specifically, the funds will be deployed to establish operations in Mumbai, Bengaluru, and Hyderabad.
This expansion plan is critical for several reasons. Moving into these tier-1 cities will allow KorinMi to tap into larger, more affluent consumer bases that are typically early adopters of premium beauty and wellness services. Opening new clinics involves significant capital expenditure, including securing prime retail locations, fitting out state-of-the-art treatment rooms with specialized Korean equipment, and hiring and training a skilled team of dermatologists, aestheticians, and support staff. It also necessitates robust marketing and brand-building efforts to establish KorinMi as a trusted name in these competitive new markets.
Beyond physical infrastructure, the funds will also implicitly support the scaling of KorinMi’s D2C product operations. As the clinic network grows, so does the potential customer base for its tailored skincare products, creating a powerful cross-promotional synergy. Investing in inventory, logistics, and digital marketing for the D2C channel will be crucial to maximize this integration and ensure a seamless customer experience across both physical and digital touchpoints.
The Vibrant Market Opportunity: Clinical Skincare and K-Beauty in India
India’s beauty and personal care market is a behemoth, projected to grow at a robust compound annual growth rate, driven by rising disposable incomes, increasing awareness of personal grooming, and the pervasive influence of global beauty trends. Within this expansive landscape, the clinical and specialized skincare segment is experiencing particularly rapid acceleration.
Consumers are moving beyond basic beauty products, seeking treatments and formulations that are backed by science, offer visible results, and address specific concerns like acne, pigmentation, and anti-aging. This shift is fueling demand for professional skin clinics that offer advanced procedures and personalized consultations. KorinMi’s model is perfectly positioned to cater to this discerning audience.
Furthermore, the ‘K-beauty’ phenomenon has transcended its niche status to become a mainstream aspiration in India. Known for its innovative ingredients, multi-step routines, and emphasis on healthy, glowing skin, Korean skincare has cultivated a loyal following. KorinMi’s unique proposition of integrating authentic Korean skin science with clinical efficacy, all while adapting treatments for Indian skin, offers a compelling value proposition that few competitors can match directly. While established players like Kaya Skin Clinic and VLCC have a strong presence, and numerous independent dermatologists offer bespoke services, KorinMi differentiates itself through its specific K-beauty clinical blend and integrated product line.
The D2C component of KorinMi’s business model also taps into another powerful trend. Direct selling to consumers allows for greater control over brand messaging, customer data, and faster product innovation cycles. It also fosters a direct relationship with the customer, building loyalty and enabling personalized recommendations, which is crucial in the high-touch skincare segment. This multi-pronged approach positions KorinMi to capture significant mindshare and market share in a segment that is still ripe for innovation and specialized offerings.
What’s Next for KorinMi: Building a Pan-Indian Clinical Skincare Brand
With this fresh capital, KorinMi is set to embark on an exciting phase of aggressive expansion. The immediate focus will be on successfully launching and establishing its presence in Mumbai, Bengaluru, and Hyderabad. This involves not only setting up physical clinics but also replicating the high standards of service and customer experience that have garnered it early success in Gurugram. Building strong local teams, establishing supply chains for its specialized Korean products and equipment, and executing targeted marketing campaigns will be paramount.
Looking ahead, KorinMi will likely continue to innovate on its D2C product front, potentially introducing new ranges that address specific skin concerns or expand into adjacent categories within the beauty and wellness space. As the company grows, investing in technology, such as advanced diagnostic tools or AI-driven personalization platforms, could further enhance its clinical offerings and customer engagement.
The partnership with Lotus Herbals, while financial, also opens doors for potential strategic collaborations, knowledge sharing, and leveraging Lotus’s deep understanding of the Indian consumer. This institutional backing provides not just capital, but also invaluable mentorship and market insights.
Ultimately, KorinMi’s trajectory suggests a clear ambition to become a leading pan-Indian brand for advanced, personalized clinical skincare rooted in Korean science. The success of its expansion into these new, competitive markets will be a critical determinant of its ability to achieve this vision and potentially pave the way for larger funding rounds from institutional venture capitalists in the future.
